Radiopharmaceuticals Market, By Type, By Radioisotope, By Application, By End User, By Geography

Description

Radiopharmaceuticals Market is estimated to be valued at USD 9,150.0 Mn in 2026 and is expected to reach USD 19,842.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 9,150.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.70%	2033 Value Projection:	USD 19,842.7 Mn

Radiopharmaceuticals are special drugs made of radioactive isotopes bound to pharmaceutical vectors for diagnostic imaging and targeted therapy. They selectively gather in specific tissues, organs or cellular receptors to help in the visualization of physiological processes and the delivery of radiation directly to diseased cells, especially in oncology. The market encompasses diagnostic agents used in PET and SPECT imaging and therapeutic agents used in targeted radionuclide therapy.

The global radiopharmaceuticals market is growing due to the rising prevalence of cancer, cardiovascular and neurological disorders, coupled with advances in nuclear medicine infrastructure, isotope production and molecular targeting. The growing adoption of targeted treatments is expanding radiopharmaceuticals beyond traditional diagnostic uses while strict requirements for manufacturing, handling, distribution and administration continue to define this highly specialized market.

Market Dynamics

The global radiopharmaceuticals market is driven by the rise in burden of cancer and other chronic diseases, increasing use of targeted radionuclide therapies and growing applications of positron emission tomography (PET) and single-photon emission computer tomography (SPECT). Rising investments in infrastructure development for nuclear medicine, isotope production and next-generation radiopharmaceuticals especially in emerging markets are other factors contributing to the market growth.

However, the growth of Radiopharmaceuticals market is limited by factors such as short half-life of isotopes, complex supply chains, stringent regulatory requirements, high manufacturing costs and lack of specialized professionals. Nevertheless, significant opportunities exist in theranostics, which combines diagnostic imaging with targeted treatment using molecularly matched radiopharmaceuticals. Advances in alpha-emitting radioisotopes such as Actinium-225, expanding therapeutic pipelines, broader clinical indications, and increasing collaborations among pharmaceutical companies, biotechnology firms, and research institutions are expected to create new avenues for market growth

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global radiopharmaceuticals market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novartis AG, GE HealthCare Technologies Inc., Cardinal Health, Inc., Curium Pharma, Lantheus Holdings, Inc., Bayer AG, Bracco Imaging S.p.A., Siemens Healthineers AG, Jubilant Pharmova Limited, and Telix Pharmaceuticals Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global radiopharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radiopharmaceuticals market

Market Segmentation

Type Insights (Revenue, USD Mn, 2021 - 2033)
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
Radioisotope Insights (Revenue, USD Mn, 2021 - 2033)
- Technetium-99m
- Fluorine-18
- Gallium-68
- Lutetium-177
- Iodine-131
- Actinium-225
- Others
Application Technique Insights (Revenue, USD Mn, 2021 - 2033)
- Oncology
- Cardiology
- Neurology
- Others
End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals and Clinics
- Diagnostic Imaging Centers
- Nuclear Medicine Centers
- Academic and Research Institutes
- Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Novartis AG
- GE HealthCare Technologies Inc.
- Cardinal Health, Inc.
- Curium Pharma
- Lantheus Holdings, Inc.
- Bayer AG
- Bracco Imaging S.p.A.
- Siemens Healthineers AG
- Jubilant Pharmova Limited
- Telix Pharmaceuticals Limited

Product Code: CMI10157

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Radiopharmaceuticals Market, By Type
- Global Radiopharmaceuticals Market, By Radioisotope
- Global Radiopharmaceuticals Market, By Application
- Global Radiopharmaceuticals Market, By End User
- Global Radiopharmaceuticals Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Industry Trends

4. Global Radiopharmaceuticals Market, By Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Diagnostic Radiopharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Therapeutic Radiopharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Radiopharmaceuticals Market, By Radioisotope, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Technetium-99m
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Fluorine-18
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Gallium-68
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Lutetium-177
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Iodine-131
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Actinium-225
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Radiopharmaceuticals Market, By Application, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Radiopharmaceuticals Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Nuclear Medicine Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Radiopharmaceuticals Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE HealthCare Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cardinal Health, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Curium Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lantheus Holdings, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bracco Imaging S.p.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Jubilant Pharmova Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Telix Pharmaceuticals Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us